Kallikrein 13 anticorps (N-Term)
Aperçu rapide pour Kallikrein 13 anticorps (N-Term) (ABIN5516816)
Antigène
Voir toutes Kallikrein 13 (KLK13) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Séquence
- GKHALGRVEA GEQVREVVHS IPHPEYRRSP THLNHDHDIM LLELQSPVQL
-
Homologie
- Cow: 86%, Dog: 100%, Horse: 100%, Human: 100%, Rabbit: 93%, Rat: 79%
-
Attributs du produit
- This is a rabbit polyclonal antibody against KLK13. It was validated on Western Blot.
-
Purification
- Affinity Purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the N-terminal region of Human KLK13
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))
-
Autre désignation
- KLK13
-
Sujet
-
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. An additional transcript variant has been identified, but its full length sequence has not been determined.
Alias Symbols: KLK13, KLKL4,
Protein Interaction Partner: SERPINF2, SERPINA1, A2M,
Protein Size: 277 -
ID gène
- 26085
-
NCBI Accession
- NP_056411
-
UniProt
- Q9UKR3
-
Pathways
- Système du Complément
Antigène
-